NASDAQ
SPNE

SeaSpine Holdings Corp

Healthcare Equipment & Supplies
Healthcare

Prices are adjusted according to historical splits.

SeaSpine Holdings Corp Stock Price

Vitals

Today's Low:
$7.83
Today's High:
$8.42
Open Price:
$7.9
52W Low:
$5.48
52W High:
$9.67
Prev. Close:
$7.92
Volume:
0

Company Statistics

Market Cap.:
$360.18 million
Book Value:
7.379
Revenue TTM:
$229.75 million
Operating Margin TTM:
-25.35%
Gross Profit TTM:
$118.83 million
Profit Margin:
-28.22%
Return on Assets TTM:
-9.53%
Return on Equity TTM:
-21.57%

Company Profile

SeaSpine Holdings Corp had its IPO on 2015-06-17 under the ticker symbol SPNE.

The company operates in the Healthcare sector and Healthcare Equipment & Supplies industry. SeaSpine Holdings Corp has a staff strength of 523 employees.

Stock update

Shares of SeaSpine Holdings Corp opened at $7.9 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $7.83 - $8.42, and closed at $8.35.

This is a +5.43% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of SeaSpine Holdings Corp have increased by +14.23%.

SeaSpine Holdings Corp's Key Ratios

SeaSpine Holdings Corp has a market cap of $360.18 million, indicating a price to book ratio of 0.9822 and a price to sales ratio of 1.1783.

In the last 12-months SeaSpine Holdings Corp’s revenue was $229.75 million with a gross profit of $118.83 million and an EBITDA of $-41757000. The EBITDA ratio measures SeaSpine Holdings Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SeaSpine Holdings Corp’s operating margin was -25.35% while its return on assets stood at -9.53% with a return of equity of -21.57%.

In Q3, SeaSpine Holdings Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 44.6%.

SeaSpine Holdings Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-1.626 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SeaSpine Holdings Corp’s profitability.

SeaSpine Holdings Corp stock is trading at a EV to sales ratio of 1.1585 and a EV to EBITDA ratio of -5.4754. Its price to sales ratio in the trailing 12-months stood at 1.1783.

SeaSpine Holdings Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$374.12 million
Total Liabilities
$55.05 million
Operating Cash Flow
$-7940000.00
Capital Expenditure
$7.94 million
Dividend Payout Ratio
0%

SeaSpine Holdings Corp ended 2024 with $374.12 million in total assets and $0 in total liabilities. Its intangible assets were valued at $374.12 million while shareholder equity stood at $274.46 million.

SeaSpine Holdings Corp ended 2024 with $3.18 million in deferred long-term liabilities, $55.05 million in other current liabilities, 372000.00 in common stock, $-319654000.00 in retained earnings and $84.60 million in goodwill. Its cash balance stood at $46.76 million and cash and short-term investments were $46.76 million. The company’s total short-term debt was $2,412,000 while long-term debt stood at $25.81 million.

SeaSpine Holdings Corp’s total current assets stands at $174.87 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $38.97 million compared to accounts payable of $17.78 million and inventory worth $83.99 million.

In 2024, SeaSpine Holdings Corp's operating cash flow was $-7940000.00 while its capital expenditure stood at $7.94 million.

Comparatively, SeaSpine Holdings Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$8.35
52-Week High
$9.67
52-Week Low
$5.48
Analyst Target Price
$15.42

SeaSpine Holdings Corp stock is currently trading at $8.35 per share. It touched a 52-week high of $9.67 and a 52-week low of $9.67. Analysts tracking the stock have a 12-month average target price of $15.42.

Its 50-day moving average was $5.7 and 200-day moving average was $6.75 The short ratio stood at 1.8 indicating a short percent outstanding of 0%.

Around 965% of the company’s stock are held by insiders while 7271.7% are held by institutions.

Frequently Asked Questions About SeaSpine Holdings Corp

The stock symbol (also called stock or share ticker) of SeaSpine Holdings Corp is SPNE

The IPO of SeaSpine Holdings Corp took place on 2015-06-17

Similar Industry Stocks (Healthcare Equipment & Supplies)

Last Price
Chg
Chg%
$94.95
0.27
+0.29%
$6.71
-0.23
-3.31%
$514.95
-23.2
-4.31%
$25.58
0.06
+0.24%
$10.85
0.03
+0.28%
$0.58
0.02
+3.57%
$509.65
-29
-5.38%
$52.4
-3.97
-7.04%
$0.53
-0.03
-5.18%
$0.13
0.01
+4.75%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

As of January 4, 2023, SeaSpine Holdings Corporation was acquired by Orthofix Medical Inc. SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company’s orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Address

5770 Armada Drive, Carlsbad, CA, United States, 92008